
Pharmacology Glossary
102 terms
- Absorption
- Drug entry into bloodstream.
- Active Ingredient
- Therapeutic component of drug.
- Adherence
- Taking drug as prescribed.
- Adverse Event Reporting
- Problem reporting.
- Adverse Reaction
- Harmful drug response.
- Agonist
- Receptor activator.
- Antagonism
- Reduced combined effect.
- Antagonist
- Receptor blocker.
- Bioavailability
- Drug amount reaching circulation.
- Bioequivalence
- Same biological effect.
- Black Box Warning
- Serious risk notice.
- Blood-Brain Barrier
- Brain protection system.
- Brand Name
- Trade name of drug.
- Carcinogenicity
- Cancer causing potential.
- Clearance
- Drug removal rate.
- Clinical Trial
- Drug testing study.
- Compliance
- Following drug instructions.
- Contraindication
- Reason not to use drug.
- Control Group
- Comparison group.
- Controlled Release
- Timed drug release.
- Cross-reactivity
- Similar drug reaction.
- Cross-tolerance
- Similar drug tolerance.
- Dependence
- Drug need development.
- Distribution
- Drug spread through body.
- Dosage Form
- Physical form of medication.
- Dose Interval
- Time between doses.
- Double Blind
- Neither knows real drug.
- Drug
- Substance affecting body function.
- Drug Delivery
- Getting drug to target.
- Drug Design
- New drug planning.
- Drug Development
- New drug creation.
- Drug-Food Interaction
- Food affecting drug.
- Drug Interaction
- Drugs affecting each other.
- Drug Monitoring
- Level checking.
- Drug Recall
- Market removal.
- Efficacy
- Drug effectiveness.
- Excipient
- Inactive drug ingredient.
- Excretion
- Drug removal from body.
- Expiration Date
- Drug use time limit.
- First Pass Effect
- Initial liver processing.
- Formulation
- Drug preparation method.
- Generic Drug
- Non-brand name drug.
- Good Manufacturing Practice
- Production standards.
- Half-life
- Time for drug level halving.
- High-Throughput Screening
- Mass drug testing.
- Idiosyncrasy
- Unusual drug response.
- Indication
- Reason to use drug.
- Inhalation
- Breathing in drug.
- Inverse Agonist
- Opposite receptor effect.
- Lead Compound
- Starting drug molecule.
- Loading Dose
- Initial higher drug dose.
- Maintenance Dose
- Regular sustaining dose.
- Mechanism of Action
- How drug works.
- Medication
- Substance used to treat disease.
- Minimum Effective Concentration
- Lowest effective drug level.
- Mutagenicity
- Gene damage potential.
- Non-competitive Inhibition
- Different site blocking.
- Oral Administration
- Taking drug by mouth.
- Over-the-counter
- No prescription needed.
- Parenteral Administration
- Non-oral drug administration.
- Partial Agonist
- Weak receptor activator.
- Patent
- Drug exclusive rights.
- Peak Level
- Maximum drug concentration.
- Personalized Medicine
- Individual drug therapy.
- Pharmaceutical
- Manufactured medical drug.
- Pharmacodynamics
- Drug effects on body.
- Pharmacogenetics
- Genetic drug response.
- Pharmacogenomics
- Genetic drug study.
- Pharmacokinetics
- Drug movement in body.
- Pharmacology
- Study of drug actions.
- Pharmacovigilance
- Safety monitoring.
- Phase III Trial
- Large scale testing.
- Phase II Trial
- Small scale efficacy test.
- Phase I Trial
- Initial human testing.
- Phase IV Trial
- Post-market monitoring.
- Placebo
- Inactive treatment.
- Post-marketing Surveillance
- After sale monitoring.
- Potentiation
- Increased drug effect.
- Prescription
- Drug order document.
- Protein Binding
- Drug-protein attachment.
- Quality Assurance
- Meeting standards.
- Randomization
- Random treatment assignment.
- Regulatory Affairs
- Rule compliance.
- Risk-Benefit Ratio
- Comparing good and bad.
- Risk Management
- Safety planning.
- Route of Administration
- Method of giving drug.
- Safety
- Freedom from harm.
- Side Effect
- Unwanted drug effect.
- Stability
- Drug unchanged storage.
- Steady State
- Stable drug concentration.
- Storage Conditions
- Drug keeping requirements.
- Structure-Activity Relationship
- Structure effect link.
- Synergism
- Enhanced combined effect.
- Tachyphylaxis
- Rapid tolerance.
- Targeted Delivery
- Specific site delivery.
- Teratogenicity
- Birth defect risk.
- Therapeutic Index
- Safety margin measure.
- Therapeutic Window
- Safe effective drug range.
- Topical Application
- Surface drug application.
- Toxic Level
- Harmful drug concentration.
- Volume of Distribution
- Drug spread measure.
- Withdrawal
- Stopping drug effects.